3CSE
Candida glabrata Dihydrofolate Reductase complexed with NADPH and 2,4-diamino-5-(3-(2,5-dimethoxyphenyl)prop-1-ynyl)-6-ethylpyrimidine (UCP120B)
3CSE の概要
| エントリーDOI | 10.2210/pdb3cse/pdb |
| 分子名称 | Dihydrofolate reductase, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine, ... (4 entities in total) |
| 機能のキーワード | protein-ligand complex, reductase, oxidoreductase |
| 由来する生物種 | Candida glabrata (yeast) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 54970.24 |
| 構造登録者 | |
| 主引用文献 | Liu, J.,Bolstad, D.B.,Smith, A.E.,Priestley, N.D.,Wright, D.L.,Anderson, A.C. Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase. Chem.Biol., 15:990-996, 2008 Cited by PubMed Abstract: Candida glabrata is a lethal fungal pathogen resistant to many antifungal agents and has emerged as a critical target for drug discovery. Over the past several years, we have been developing a class of propargyl-linked antifolates as antimicrobials and hypothesized that these compounds could be effective inhibitors of dihydrofolate reductase (DHFR) from C. glabrata. We initially screened a small collection of these inhibitors and found modest levels of potency. Subsequently, we determined the crystal structure of C. glabrata DHFR bound to a representative inhibitor with data to 1.6 A resolution. Using this structure, we designed and synthesized second-generation inhibitors. These inhibitors bind the C. glabrata DHFR enzyme with subnanomolar potency, display greater than 2000-fold levels of selectivity over the human enzyme, and inhibit the growth of C. glabrata at levels observed with clinically employed therapeutics. PubMed: 18804036DOI: 10.1016/j.chembiol.2008.07.013 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






